合成路线1
该中间体在本合成路线中的序号:
(III) The reaction of o-chlorophenylacetic acid (I) with SOCl2 gives the corresponding acyl chloride (II), which is condensed with 2-(methylamino) ethanol (III) yielding o-chloro-N-methyl-N-(2-hydroxyethyl)phenylacetamide (IV). The reduction of (IV) with diborane in THF affords N-methyl-N-(2-hydroxyethyl)-2-(2-chlorophenyl)ethylamine (V), which by reaction with PCl5 in CHCl3 is con-verted into N-methyl-N-(2-chloroethyl)-2-(2-chlorophenyl)ethylamine (VI). Finally, this compound is cyclized by means of anhydrous AlCl3-NH4Cl at 175 C.
【1】
Holden K.G.; Kaiser, C. (SmithKline Beecham Corp.); 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity. EP 0007070; EP 0080012; ES 482276; ES 482281; JP 8011584; US 4265890 . |
【2】
Castaner, J.; Serradell, M.N.; Badia, A.; SKF-86466. Drugs Fut 1984, 9, 2, 119.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29994 |
2-(2-chlorophenyl)acetic acid
|
2444-36-2 |
C8H7ClO2 |
详情 | 详情
|
(II) |
29995 |
2-(2-chlorophenyl)acetyl chloride
|
|
C8H6Cl2O |
详情 |
详情
|
(III) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(IV) |
29996 |
2-(2-chlorophenyl)-N-(2-hydroxyethyl)-N-methylacetamide
|
|
C11H14ClNO2 |
详情 |
详情
|
(V) |
10207 |
2-[(2-Chlorophenethyl)(methyl)amino]-1-ethanol
|
|
C11H16ClNO |
详情 |
详情
|
(VI) |
29997 |
N-(2-chloroethyl)-N-(2-chlorophenethyl)-N-methylamine; 2-chloro-N-(2-chlorophenethyl)-N-methyl-1-ethanamine
|
|
C11H15Cl2N |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) The condensation of labeled 2-(3-chlorphenyl)acetic acid (I) with N-methylethanolamine (II) by means of SOCl2 gives the corresponding amide (III), which is reduced with BH3, yielding the tertiary amine (IV). The reaction of (IV) with PCl3 affords the chloroethylamine (V), which is finally cyclized by means of AlCl3 to provide the target benzazepine.
【1】
Hieble, J.P.; Wilson III, J.W.; Weinstock, J.; The chemistry and pharmacology of 3-benzazepines derivatives. Drugs Fut 1985, 10, 8, 645.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
39705 |
2-(3-chlorophenyl)acetic acid; 3-chlorophenylacetic acid
|
1878-65-5 |
C8H7ClO2 |
详情 | 详情
|
(I) |
44628 |
2-(3-chlorophenyl)acetic acid
|
|
C8H7ClO2 |
详情 |
详情
|
(II) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(III) |
44044 |
2-(3-chlorophenyl)-N-(2-hydroxyethyl)-N-methylacetamide
|
|
C11H14ClNO2 |
详情 |
详情
|
(III) |
44629 |
2-(3-chlorophenyl)-N-(2-hydroxyethyl)-N-methylacetamide
|
|
C11H14ClNO2 |
详情 |
详情
|
(IV) |
44045 |
2-[(3-chlorophenethyl)(methyl)amino]-1-ethanol
|
|
C11H16ClNO |
详情 |
详情
|
(IV) |
44630 |
2-[(3-chlorophenethyl)(methyl)amino]-1-ethanol
|
|
C11H16ClNO |
详情 |
详情
|
(V) |
44046 |
2-chloro-N-(3-chlorophenethyl)-N-methyl-1-ethanamine; N-(2-chloroethyl)-N-(3-chlorophenethyl)-N-methylamine
|
|
C11H15Cl2N |
详情 |
详情
|
(V) |
44631 |
2-chloro-N-(3-chlorophenethyl)-N-methyl-1-ethanamine; N-(2-chloroethyl)-N-(3-chlorophenethyl)-N-methylamine
|
|
C11H15Cl2N |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(VI) beta-Methylaminoethanol (VI) is treated with ethyl chlorocarbonate in triethylamine to give ethyl N-methyl-hydroxyethylcarbamate (VII), which is treated with thionyl chloride to give ethyl-N-methyl-beta-chloroethylcarbamate (VIII). Compound (VIII) is treated with 5H-dibenzo[a,d]cyclohepten-5-one oxime (I) and the resulting product is decomposed without isolation.
【1】
Pirola, O.; Rossi, S.; Fanelli, O.; Maggi, R.; O- And N- substituted 5H-dibenzo[a,d]cyclohepten-5-one oximes with thymoleptic acticity. VII. Synthesis and pharmacological properties of the substituted oximes. Farm Sci Ed 1969, 24, 7, 685-703.
|
【2】
Castaner, J.; Serradell, M.N.; Blancafort, P.; Demexiptiline hydrochloride. Drugs Fut 1982, 7, 1, 19.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31713 |
5H-dibenzo[a,d]cyclohepten-5-one oxime
|
|
C15H11NO |
详情 |
详情
|
(VI) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(VII) |
31717 |
ethyl 2-hydroxyethyl(methyl)carbamate
|
|
C6H13NO3 |
详情 |
详情
|
(VIII) |
31718 |
ethyl 2-chloroethyl(methyl)carbamate
|
|
C6H12ClNO2 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(XIX) In a different method, reaction of styrene oxide (XV) with methylamine provided amino alcohol (XVI), which was further condensed with ethylene oxide (XVII) to afford amino diol (XVIII). Alternatively, diol (XVIII) was prepared by a more direct procedure by condensation of epoxide (XV) with 2-(methylamino)ethanol (XIX). Chlorination of (XVIII) employing SOCl2 yielded the dichloro derivative (XX), which was subsequently condensed with 2-aminobenzyl alcohol (X) leading to piperazine (XXI). Cyclization of (XXI) to the title compound was accomplished by treatment with hot polyphosphoric acid. Optionally, alcohol (XXI) was converted to chloride (XXII), which was then cyclized in the presence of AlCl3. In a related method, alcohol (XXI) was esterified with AcOH, and the resultant acetate ester (XXIII) was then cyclized in the presence of polyphosphoric acid
【1】
Olivié, J.; Synthesis for the preparation of tetracyclic cpds.. US 4217452 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
18619 |
(2-aminophenyl)methanol; 2-Amino-benzenemethanol;2-Hydroxymethyl aniline;2-aminobenzyl alcohol;o-Aminobenzyl 2-aminobenzylalcohol;alcohol; 2-aminobenzenemethanol; 2-aminobenzyl alcohol |
5344-90-1 |
C7H9NO |
详情 | 详情
|
(XV) |
23017 |
2-phenyloxirane
|
96-09-3 |
C8H8O |
详情 | 详情
|
(XVI) |
62404 |
2-(methylamino)-1-phenyl-1-ethanol
|
|
C9H13NO |
详情 |
详情
|
(XVII) |
10393 |
Oxirane; Ethylene oxide
|
75-21-8 |
C2H4O |
详情 | 详情
|
(XVIII) |
62405 |
2-[(2-hydroxyethyl)(methyl)amino]-1-phenyl-1-ethanol
|
|
C11H17NO2 |
详情 |
详情
|
(XIX) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(XX) |
62406 |
2-chloro-N-(2-chloroethyl)-N-methyl-2-phenyl-1-ethanamine; N-(2-chloroethyl)-N-(2-chloro-2-phenylethyl)-N-methylamine
|
|
C11H15Cl2N |
详情 |
详情
|
(XXI) |
62407 |
[2-(4-methyl-2-phenyl-1-piperazinyl)phenyl]methanol
|
|
C18H22N2O |
详情 |
详情
|
(XXII) |
62408 |
1-[2-(chloromethyl)phenyl]-4-methyl-2-phenylpiperazine
|
|
C18H21ClN2 |
详情 |
详情
|
(XXIII) |
62409 |
2-(4-methyl-2-phenyl-1-piperazinyl)benzyl acetate
|
|
C20H24N2O2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) Elgodipine can be obtained in three main steps:
The alkylation of N-methyl-2-aminoethanol (I) with 4-fluorobenzyl chloride (II) gives 2-[N-(4-fluorobenzyl)-N-methylamino]ethanol (III), which is esterified with 2,2,6-trimethyl-4H-1,3-dioxin-4-one (IV) yielding the corresponding acetoacetic ester (V). The condensation of (V) with 2,3-methylenedioxybenzaldehyde (VI) affords 2-[N-(4-fluorobenzyl)-N-methylamino]ethyl 2-(2,3-methylenedioxybenzylidene]acetoacetate (VII), which is finally cyclized with isopropyl 3-aminocrotonate (VIII).
The intermediate aldehyde (VI) is obtained starting from 2,3-dimethoxybenzaldehyde (X), which by demethylation with HCl or HBr yields 2,3-dihydroxybenzaldehyde (XI). Finally, this compound is converted into (VI) in the usual way.
The intermediate crotonate (VIII) is obtained by reaction of isopropyl acetoacetate (IX) with ammonia.
【1】
Galiano, A.; Elgodipine Hydrochloride. Drugs Fut 1995, 20, 3, 231.
|
【2】
Fernandez Torija, C.; Galiano Ramos, J.A. (IIDQB (Madrid)); 1,4-Dihydropyridines, process for their preparation and their use as medicaments. AU 8820330; BE 1001055; CH 675999; EP 0302980; GB 2208861; JP 1989294675; US 4952592 .
|
【3】
Serradell, M.N.; Castaner, J.; Castaner, R.M.; Oxodipine. Drugs Fut 1987, 12, 7, 633.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(II) |
12354 |
4-Fluorobenzyl chloride; 1-(Chloromethyl)-4-fluorobenzene
|
352-11-4 |
C7H6ClF |
详情 | 详情
|
(III) |
13333 |
2-[(4-Fluorobenzyl)(methyl)amino]-1-ethanol
|
|
C10H14FNO |
详情 |
详情
|
(IV) |
13327 |
2,2,6-Trimethyl-4H-1,3-dioxin-4-one;2,2,6-trimethyl-1,3-dioxin-4-one;2,2,6-trimethyl-m-Dioxin-4-one;3-(1-hydroxy-1-methylethoxy)-d-lactone Crotonicacid |
5394-63-8 |
C7H10O3 |
详情 | 详情
|
(V) |
13328 |
2-[(4-fluorobenzyl)(methyl)amino]ethyl 3-oxobutanoate
|
|
C14H18FNO3 |
详情 |
详情
|
(VI) |
13329 |
2,3-(Methylenedioxy)benzaldehyde; 1,3-Benzodioxole-4-carbaldehyde
|
7797-83-3 |
C8H6O3 |
详情 | 详情
|
(VII) |
13330 |
2-[(4-fluorobenzyl)(methyl)amino]ethyl (Z)-2-acetyl-3-(1,3-benzodioxol-4-yl)-2-propenoate
|
|
C22H22FNO5 |
详情 |
详情
|
(VIII) |
13331 |
isopropyl (E)-3-amino-2-butenoate
|
143093-33-8 |
C7H13NO2 |
详情 | 详情
|
(IX) |
13332 |
isopropyl 3-oxobutanoate; Isopropyl acetoacetate
|
542-08-5 |
C7H12O3 |
详情 | 详情
|
(X) |
17615 |
2,3-Dimethoxybenzaldehyde
|
86-51-1 |
C9H10O3 |
详情 | 详情
|
(XI) |
12380 |
2,3-Dihydroxybenzaldehyde
|
24677-78-9 |
C7H6O3 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The reaction of 2-chloropyridine (I) with 2-(methyl-amino)ethanol (II) by heating at 150 C gives 2-[N-methyl-N-(2-pyridyl)amino]ethanol (III), which is condensed with 4-fluorobenzaldehyde (IV) by means of NaH in DMF, yielding 4-[2-[N-methyl-N-(2-pyridyl)amino]-ethoxy]benzaldehyde (V) (1-3). The reaction of (V) with thiazolidine-2,4-dione (VI) by means of piperidinium acetate in refluxing toluene affords 5-[4-[2-[N-methyl-N-(2-pyridyl)- amino]ethoxy]benzylidene]thiazolidine-2,4-dione (VII). Finally, this compound is reduced with H2 over Pd/C (1), Mg in methanol (2,3) or biocatalytically by incubation with whole cells of the yeast Rhodotorula rubra CBS 6469 at pH 7.5-8.0 (4-6). Under acidic conditions, pH 3.0-5.0, this microbial biotransformation is enantioselective, giving the (+)-(R)-enantiomer of rosiglitazone.
【1】
Jones, J.J.; Verrall, M.S.; Heath, C.M.; Imrie, R.C.; Rees, M.J.; Robins, K.G.; Whole cell biotransformation of 5-(4-(2-(2-pyridyl)methylamino)ethoxy)benzylidenethiazolidine-2,4-dione to its benzyl derivative using a yeast reductase. J Chem Tech Biotech 1997, 68, 324-30. |
【2】
Cantello, B.C.C.; Haigh, D.; Eggleston, D.S.; Jennings, K.R.; Heath, C.M.; Sime, J.T.; Haltiwanger, R.C.; Woroniecki, S.R.; Hindley, R.M.; Facile biocatalytic reduction of the carbon-carbon double bond of 5-benzylidenethiazolidine-2,4-diones. Synthesis of (?-5-(4-(2-[methyl(2-pyridyl)amino]ethoxy)benzyl)-thiazolidine-2,4-dione (BRL 49653), its (R)-(?-enantiomer and analogues. J Chem Soc - Perkins Trans I 1994, 22, 22, 3319-24. |
【3】
Thurlby, P.L.; Lister, C.A.; Duff, P.T.; Hindley, R.M.; Cottam, G.P.; Haigh, D.; Smith, S.A.; Cantello, BB.C.C.; Cawthorne, M.A.; [[*-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. J Med Chem 1994, 37, 23, 3977-85. |
【4】
Sorbera, L.A.; Rabasseda, X.; Leeson,P.A.; Rosiglitazone Maleate. Drugs Fut 1998, 23, 9, 977.
|
【5】
Hindley, R.M. (SmithKline Beecham plc); Substd. Thiazolidine-dione derivs. AU 8821738; EP 0306228; EP 0842925; JP 1989131169; JP 1997183726; JP 1997183771; JP 1997183772; JP 1998194970; JP 1998194971; US 5002953; US 5194443; US 5232925; US 5646169 .
|
【6】
Hindley, R.M.; Woroniecki, S.R. (SmithKline Beecham plc); Process for the preparation of pharmaceutically active thiazolidine or oxazolidine cpds. by a yeast reductase. WO 9310254 .
|
【7】
Vyas, S.K. (Torrent Pharmaceuticals Ltd.); Process for the preparation of rosiglitazone maleate. US 2002115866; US 6515132; WO 0251823 .
|
【8】
Smith, S.A.; Thurlby, P.L.; Cantello, B.C.C.; Haigh, D.; Cawthorne, M.A.; Hindley, R.M.; The synthesis of BRL 49653 - A novel and potent antihyperglycaemic agent. Bioorg Med Chem Lett 1994, 4, 10, 1181-4.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17503 |
2-chloropyridine
|
109-09-1 |
C5H4ClN |
详情 | 详情
|
(II) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(III) |
17505 |
2-[methyl(2-pyridinyl)amino]-1-ethanol
|
|
C8H12N2O |
详情 |
详情
|
(IV) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(V) |
17507 |
4-[2-[methyl(2-pyridinyl)amino]ethoxy]benzaldehyde
|
|
C15H16N2O2 |
详情 |
详情
|
(VI) |
10883 |
1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione
|
2295-31-0 |
C3H3NO2S |
详情 | 详情
|
(VII) |
17509 |
5-[(E)-(4-[2-[methyl(2-pyridinyl)amino]ethoxy]phenyl)methylidene]-1,3-thiazolidine-2,4-dione
|
122320-74-5 |
C18H17N3O3S |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(III) Treatment of chromane (I) with metanesulfonyl chloride in pyridine at 0 C afforded mesylate (II), which was treated with 2-methylaminoethanol (III) to afford tertiary amine (IV). Reaction with SOCl2 gave chloride (V), and further reaction with p-hydroxybenzaldehyde (VI) provided (VII). Aldehyde (VII) was then condensed with 2,4-thiazolidinedione (VIII) in the presence of piperidine benzoate in toluene to furnish (IX). Finally, the benzyl protecting group was removed by treatment with acetic acid-hydrochloric acid at 60 C to give the title compound.
【1】
Reddy, K.A.; Lohray, B.B.; Bhushan, V.; Reddy, A.S.; Kishore, P.H.; Rao, VV.; Saibaba, V.; Bajji, A.C.; Rajesh, B.M.; Reddy, K.V.; Chakrabarti, R.; Rajagopalan, R.; Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif. Bioorg Med Chem Lett 1998, 8, 9, 999-1002. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18084 |
[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methanol
|
|
C21H26O3 |
详情 |
详情
|
(II) |
18085 |
[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl methanesulfonate
|
|
C22H28O5S |
详情 |
详情
|
(III) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(IV) |
18086 |
2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]-1-ethanol
|
|
C24H33NO3 |
详情 |
详情
|
(V) |
18087 |
N-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]-N-(2-chloroethyl)-N-methylamine; N-[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl]-2-chloro-N-methyl-1-ethanamine
|
|
C24H32ClNO2 |
详情 |
详情
|
(VI) |
13433 |
4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde
|
123-08-0 |
C7H6O2 |
详情 | 详情
|
(VII) |
18088 |
4-[2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]ethoxy]benzaldehyde
|
|
C31H37NO4 |
详情 |
详情
|
(VIII) |
10883 |
1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione
|
2295-31-0 |
C3H3NO2S |
详情 | 详情
|
(IX) |
18089 |
5-[(Z)-(4-[2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]ethoxy]phenyl)methylidene]-1,3-thiazolidine-2,4-dione
|
|
C34H38N2O5S |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) A new synthesis of the title compound, very similar to that already published, is reported:
The condensation of 6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-ylmethyl methanesulfonate (I) with 2-(methylamino)ethanol (II) by heating at 120 C gives the tertiary amine (III), which is condensed with 4-fluorobenzaldehyde (IV) by means of NaH in DMF yielding the 4-alkoxy benzaldehyde (V). A new condensation of (V) with thiazolidine-2,4-dione (VI) by means of piperidine in refluxing toluene affords the benzyloxy derivative of the target compound (VII). Finally, the target compound is obtained by treatment of (VII) with HCl in acetic acid.
【1】
Casturi, S.R.; Lohray, V.B.; Kallam, A.R.; Pingali, H.; Ramanujam, R.; Alla, S.R. (Dr. Reddy's Research Foundation); Cpds. having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compsns. containing them. US 5925656 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26454 |
6-(benzyloxy)-2,5,7,8-tetramethyl-2-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)chromane
|
|
C24H32O3S |
详情 |
详情
|
(II) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(III) |
18086 |
2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]-1-ethanol
|
|
C24H33NO3 |
详情 |
详情
|
(IV) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(V) |
18088 |
4-[2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]ethoxy]benzaldehyde
|
|
C31H37NO4 |
详情 |
详情
|
(VI) |
10883 |
1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione
|
2295-31-0 |
C3H3NO2S |
详情 | 详情
|
(VII) |
18089 |
5-[(Z)-(4-[2-[[[6-(benzyloxy)-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]methyl](methyl)amino]ethoxy]phenyl)methylidene]-1,3-thiazolidine-2,4-dione
|
|
C34H38N2O5S |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) The condensation of 5-(benzyloxy)-2,2,4,6,7-pentamethyl-3,4-dihydrobenzofuran-3-ylmethyl methanesulfonate (I) with 2-(methylamino)ethanol (II) by heating at 120 C gives the tertiary amine (III), which is treated with SOCl2 in benzene yielding the chloroethylamino compound (IV). The condensation of (IV) with 4-nitrophenol (V) by means of K2CO3 in hot DMF affords the 4-nitrophenoxy compound (VI), which is reduced with H2 over Pd/C in ethyl acetate to the corresponding 4-aminophenoxy compound (VII). The condensation of (VII) with ethyl acrylate (VIII) by means of NaNO2 and HBr in methanol/water gives the 2-bromopropionic ester (IX), which is cyclized with thiourea (X) by means of NaOAc in refluxing ethanol yielding the thiazolidinedione (XI). Finally, this compound is debenzylated with HCl in hot acetic acid.
【1】
Casturi, S.R.; Lohray, V.B.; Kallam, A.R.; Pingali, H.; Ramanujam, R.; Alla, S.R. (Dr. Reddy's Research Foundation); Cpds. having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compsns. containing them. US 5925656 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26455 |
5-(benzyloxy)-2,2,4,6,7-pentamethyl-3-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)-2,3-dihydro-1-benzofuran
|
|
C24H32O3S |
详情 |
详情
|
(II) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(III) |
26456 |
2-[[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl](methyl)amino]-1-ethanol
|
|
C24H33NO3 |
详情 |
详情
|
(IV) |
26457 |
N-[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl]-2-chloro-N-methyl-1-ethanamine
|
|
C24H32ClNO2 |
详情 |
详情
|
(V) |
11236 |
4-Nitrophenol; p-Nitrophenol
|
100-02-7 |
C6H5NO3 |
详情 | 详情
|
(VI) |
26458 |
N-[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl]-N-methyl-2-(4-nitrophenoxy)-1-ethanamine
|
|
C30H36N2O5 |
详情 |
详情
|
(VII) |
26459 |
4-[2-[[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl](methyl)amino]ethoxy]aniline
|
|
C30H38N2O3 |
详情 |
详情
|
(VIII) |
10164 |
ethyl acrylate
|
140-88-5 |
C5H8O2 |
详情 | 详情
|
(IX) |
26460 |
ethyl 3-(4-[2-[[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl](methyl)amino]ethoxy]phenyl)-2-bromopropanoate
|
|
C35H44BrNO5 |
详情 |
详情
|
(X) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(XI) |
26461 |
5-(4-[2-[[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl](methyl)amino]ethoxy]benzyl)-1,3-thiazolidine-2,4-dione
|
|
C34H40N2O5S |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(IV) The 2-aminobenzophenone derivative (III) was prepared by condensation of L-tyrosine methyl ester (I) with 2-benzoylcyclohexanone (II) in refluxing anisole, with concomitant dehydrogenation in the presence of Pd/C. Subsequent Mitsunobu coupling of (III) with 2-(N-Boc-N-methylamino)ethanol (V), prepared from aminoalcohol (IV) and Boc2O, afforded the Boc-protected aminoethyl ether (VI). After removal of the Boc group of (VI) by treatment with trifluoroacetic acid, condensation of the resulting secondary amine (VII) with 2-fluoropyridine (VIII) yielded the 2-aminopyridine derivative (IX). Finally, the methyl ester group of (IX) was hydrolyzed to the title carboxylic acid using LiOH.
【1】
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
|
【2】
Willson, T.M.; Mook, R.A. Jr.; Kaldor, I.; Henke, B.R.; Deaton, D.N.; Collins, J.L.; Cobb, J.E.; Brackeen, M.; Sharp, M.J.; O'Callaghan, J.M.; Erickson, G.A.; Boswell, G.E. (Glaxo Wellcome plc); Substd. 4-hydroxy-phenylalkanoic acid derivs. with agonist activity to PPAR-gamma. EP 0888317; JP 2000507216; WO 9731907 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
23767 |
Methoxybenzene; Methyl phenyl ether; Anisole
|
100-66-3 |
C7H8O |
详情 | 详情
|
(I) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(II) |
21432 |
2-benzoylcyclohexanone
|
3580-38-9 |
C13H14O2 |
详情 | 详情
|
(III) |
21434 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate
|
|
C23H21NO4 |
详情 |
详情
|
(IV) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(V) |
34509 |
tert-butyl 2-hydroxyethyl(methyl)carbamate
|
|
C8H17NO3 |
详情 |
详情
|
(VI) |
34510 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-[2-[(tert-butoxycarbonyl)(methyl)amino]ethoxy]phenyl)propanoate
|
|
C31H36N2O6 |
详情 |
详情
|
(VII) |
34511 |
methyl (2S)-2-(2-benzoylanilino)-3-[4-[2-(methylamino)ethoxy]phenyl]propanoate
|
|
C26H28N2O4 |
详情 |
详情
|
(VIII) |
34512 |
2-fluoropyridine
|
372-48-5 |
C5H4FN |
详情 | 详情
|
(IX) |
34513 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-[2-[methyl(2-pyridinyl)amino]ethoxy]phenyl)propanoate
|
|
C31H31N3O4 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(IX) The formylation of 3,5-dichloropyridine (I) with methyl formate (II), BuLi and DIEA in THF gives 3,5-dichloropyridine-4-carbaldehyde (III), which is treated with 4-bromophenol (IV) and potassium tert-butoxide in hot THF to yield the adduct (V). This compound, without isolation is cyclized with methyl 2-mercaptoacetate (VI) by means of Cs2CO3 to afford 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VII), which is hydrolyzed with LiOH in THF/water to provide the corresponding carboxylic acid (VIII). Finally, this compound is condensed with ethanolamine (IX) by means of EDC and HOBt in DMF to give the target ethanolamide.
Alternatively, the target amide can also be obtained by direct reaction of methyl ester (VII) with ethanolamine (IX) in refluxing methanol.
【1】
Zhu, G.-D.; et al.; Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)theino[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001, 44, 21, 3469.
|
【2】
Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35535 |
3,5-dichloropyridine
|
2457-47-8 |
C5H3Cl2N |
详情 | 详情
|
(II) |
45474 |
methyl formate
|
107-31-3 |
C2H4O2 |
详情 | 详情
|
(III) |
35536 |
3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde |
136590-83-5 |
C6H3Cl2NO |
详情 | 详情
|
(IV) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(V) |
52015 |
3-(4-bromophenoxy)-5-chloroisonicotinaldehyde
|
|
C12H7BrClNO2 |
详情 |
详情
|
(VI) |
18838 |
methyl 2-sulfanylacetate
|
2365-48-2 |
C3H6O2S |
详情 | 详情
|
(VII) |
52016 |
methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate
|
|
C15H10BrNO3S |
详情 |
详情
|
(VIII) |
52017 |
4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid
|
|
C14H8BrNO3S |
详情 |
详情
|
(IX) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) The reaction of 3-phenylphthalide (I) with N-methylethanolamine (II) in refluxing benzene gives N-(2-hydroxyethyl)-2-(1-hydroxy-1-phenylmethyl)-N-methylbenzamide (III), which is cyclized by means of Ts-OH in refluxing toluene to yield 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocin-6-one (IV). Finally this compound is reduced with LiAlH4 in refluxing THF to afford the target benzoxazocine.
In an alternative method, the reduction of 2-benzoyl-N-(2-hydroxyethyl)-N-methylbenzamide (V) by means of sodium bis(2-methoxyethoxy)aluminum hydride in refluxing toluene gives the diol (VI), which is then cyclized by means of Ts-OH in refluxing toluene, or by means of aq. 48% HBr in hot chloroform to afford the target benzoxazocine.
【1】
Lucero de Pablo, M.L.; Martin-Escudero Perez, U.; Izquierdo Sanjose, M.; Process for the preparation of a benzoxazine deriv. and its non-toxic salt. ES 8105723 .
|
【2】
Eberlin, J.W.; Process for benz[f]-2,5-oxazocines. US 3978085 .
|
【3】
Gimbert Roura, J.; Soler Peix, E.; Process for the preparation of benzoxazines. KE 8201564 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59371 |
3-Phenyl-1(3H)-isobenzofuranone; 3-Phenylphthalide
|
5398-11-8 |
C14H10O2 |
详情 | 详情
|
(II) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(III) |
59372 |
N-(2-hydroxyethyl)-2-[hydroxy(phenyl)methyl]-N-methylbenzamide
|
|
C17H19NO3 |
详情 |
详情
|
(IV) |
59373 |
5-methyl-1-phenyl-4,5-dihydro-1H-2,5-benzoxazocin-6(3H)-one
|
|
C17H17NO2 |
详情 |
详情
|
(V) |
59374 |
2-benzoyl-N-(2-hydroxyethyl)-N-methylbenzamide
|
24833-47-4 |
C17H17NO3 |
详情 | 详情
|
(VI) |
59375 |
2-[{2-[hydroxy(phenyl)methyl]benzyl}(methyl)amino]-1-ethanol
|
|
C17H21NO2 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(III) The reaction of 2-benzoylbenzoic acid (I) with PCl3 in dichloromethane gives the corresponding acyl chloride (II), which is condensed with N-methylethanolamine (III) by means of TEA In dichloroethane to yield the amide (IV). The reaction of (IV) with PCl3 in dichloroethane affords the 2-chloroethylamide (V), which is reduced with NaBH4 and A-OH in dichloromethane to provide the diol (VI). Finally, this compound is cyclized by means of aq. HBr in dichloroethane to give the target benzoxazocine.
【1】
Watson, P.G.; Process for the preparation of 2-[N-(2-hydroxyethyl)-N-lower alkylaminomethyl]benzhydrols. US 4208349 .
|
【2】
Watson, P.G.; Process for the preparation of 2-[N-(2-hydroxyethyl)-N-lower alkylaminomethyl)benzhydrols. GB 1586578 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59365 |
2-benzophenone carboxylic acid; 2-Benzoylbenzoic acid; 2-Carboxybenzophenone; Benzophenone-2-carboxylic acid; O-benzoylbenzoic acid
|
85-52-9 |
C14H10O3 |
详情 | 详情
|
(II) |
59366 |
2-benzoylbenzoyl chloride
|
|
C14H9ClO2 |
详情 |
详情
|
(III) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(IV) |
59374 |
2-benzoyl-N-(2-hydroxyethyl)-N-methylbenzamide
|
24833-47-4 |
C17H17NO3 |
详情 | 详情
|
(V) |
59377 |
2-benzoyl-N-(2-chloroethyl)-N-methylbenzamide
|
|
C17H16ClNO2 |
详情 |
详情
|
(VI) |
59375 |
2-[{2-[hydroxy(phenyl)methyl]benzyl}(methyl)amino]-1-ethanol
|
|
C17H21NO2 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) The title compound is prepared using nocathiacin I (I) as the starting material. Michael addition of 2-(methylamino)ethanol (II) to the conjugated amide function of (I) in aqueous solution gives rise to the target diaminopropionamide derivative.
【1】
Bronson, J.J.; Lam, K.S.; Ueda, Y.; Wichtowski, J.A.; Sorenson, M.E.; Li, W.; Kim, O.K.; Zhang, Y.; Naidu, B.N.; Connolly, T.P. (Bristol-Myers Squibb Co.); Water soluble thiazolyl peptide derivs.. WO 0214354 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
63593 |
2-(1-(aminocarbonyl)-2-{(E)-[5-(4-nitrophenyl)-2-furyl]methylidene}hydrazino)acetic acid
|
|
C14H12N4O6 |
详情 |
详情
|
(II) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(II)
【1】
Li JM,Li F,Cha DJ.2001.Synthesis of antihyperglycemic agent rosiglitazone. 中国药物化学杂志.11 : 291~292(本论文作者来自于Dpartment of Pharmaceutical Chemistry,Anhui College of TCM.Hefei, Peop Rep China) |
【2】
Nambiar S. Pise AC. 2005. Process for preparing thiazolidinediones such as pioglitazone via reduction of exocyclic double bonds at the 5-position of thiazolidinediones using dithionite. W0 2005049610(本专利属于Sandoz A-G.Switz) |
【3】
Vyas SK. 2002. Process for the preparation of rosiglitazone maleate. W0 2002051823 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17503 |
2-chloropyridine
|
109-09-1 |
C5H4ClN |
详情 | 详情
|
(II) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(III) |
17505 |
2-[methyl(2-pyridinyl)amino]-1-ethanol
|
|
C8H12N2O |
详情 |
详情
|
(IV) |
10883 |
1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione
|
2295-31-0 |
C3H3NO2S |
详情 | 详情
|
(V) |
17507 |
4-[2-[methyl(2-pyridinyl)amino]ethoxy]benzaldehyde
|
|
C15H16N2O2 |
详情 |
详情
|
(VI) |
10883 |
1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione
|
2295-31-0 |
C3H3NO2S |
详情 | 详情
|